Literature DB >> 4373870

Stimulation of human platelet adenylate cyclase by prostaglandin D2.

D C Mills, D E Macfarlane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4373870     DOI： 10.1016/0049-3848(74)90176-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  22 in total

1.  Prostaglandins and the human mucosal alimentary cyclic AMP system.

Authors:  B Simon; H Kather
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

Review 2.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

3.  Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.

Authors:  K H Jakobs; W Saur; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

Review 4.  Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Authors:  H Patscheke
Journal:  Blut       Date:  1990-05

5.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

6.  Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.

Authors:  K A Williams; W Murphy; R J Haslam
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 7.  Metabolic interactions between eicosanoids in blood and vascular cells.

Authors:  M Lagarde; N Gualde; M Rigaud
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

8.  Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.

Authors:  P Gresele; J Arnout; H Deckmyn; E Huybrechts; G Pieters; J Vermylen
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  AH6809, a prostaglandin DP-receptor blocking drug on human platelets.

Authors:  R J Keery; P Lumley
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

10.  Selective binding site for [3H]prostacyclin on platelets.

Authors:  A M Siegl; J B Smith; M J Silver; K C Nicolaou; D Ahern
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.